Ajinomoto Co., Inc. (2802.T)
Tokyo, JP
Ajinomoto Co., Inc. is a Japanese multinational corporation with a global presence, specializing in three main business areas: seasonings and food products, frozen culinary items, and a diverse healthcare and specialty chemicals portfolio. Its Seasonings and Foods division offers an extensive range of sauces and seasonings, featuring well-known brands such as AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY. This segment also provides tailored ingredient solutions for both consumer packaged goods and the food service industry. Beyond culinary staples, it includes popular instant noodle brands like Knorr Cup Soup and YumYum, various coffee products under the Birdy and Blendy labels, the Birdy 3in1 powdered drink, MAXIM products, and Chyotto Zeitakuna Kohiten items. Additionally, it supplies gift sets and office amenities, including coffee vending machines and tea servers. Within the Frozen Foods segment, the company produces a variety of convenient meal options such as Chinese dumplings, cooked rice dishes, noodles, desserts, shumai, and processed chicken products. The Healthcare and Other segment demonstrates significant diversification. It supplies amino acids for a range of applications in the pharmaceutical, food, and cosmetic industries, alongside sports nutrition products and personal care ingredients. This division also provides sterile products and specialized contract manufacturing services for pharmaceutical intermediates and active ingredients. A notable offering is the Ajinomoto Build-up Film, an advanced interlayer insulating material crucial for semiconductor packages. Ajinomoto Co., Inc. was established in 1909 and maintains its headquarters in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.46% | +10.34% | +17.45% | +25.44% | +41.92% | +64.38% | +68.12% | +125.27% | +352.04% | +339.94% | +869.65% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 5 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +5.3%+6.4% ★ Q1'26: +10.5% (vs Q1'25)
-
EPS growth Packaged Foods: +8.0%-58.3% Q1'26: +480.8% (vs Q1'25)
-
FCF margin Packaged Foods: +15.4%+5.2% Q1'26: +13.1% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.7%+8.0% ★ Q1'26: +8.0% (vs Q1'25)
-
ROIC Packaged Foods: +7.3%+7.7% ★ Q1'26: +9.3% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+93.5% Q1'26: -4.1% (vs Q1'25)
-
Debt / EBITDA Packaged Foods: 0.29×2.37× Q1'26: 1.84× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 14 Rev. Ana. 12 EPS Ana. |
Mar 2027 10 Rev. Ana. 14 EPS Ana. |
Mar 2028 13 Rev. Ana. 13 EPS Ana. |
Mar 2029 6 Rev. Ana. 6 EPS Ana. |
Mar 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.01T
est: 1.01T (-0.4%)
|
1.15T
est: 1.22T (-6.1%)
|
1.09T
est: 1.10T (-1.1%)
|
1.11T
est: 1.15T (-3.2%)
|
1.11T
est: 1.14T (-2.0%)
|
1.10T
est: 1.11T (-1.1%)
|
1.07T
est: 1.08T (-0.3%)
|
1.15T
est: 1.15T (+0.2%)
|
1.36T
est: 1.37T (-0.8%)
|
1.44T
est: 1.47T (-1.8%)
|
1.53T
est: 1.54T (-0.8%)
|
1.58T
1.55T – 1.62T
+2.7% YoY
|
1.69T
1.68T – 1.73T
+6.8% YoY
|
1.79T
1.75T – 1.84T
+5.9% YoY
|
1.89T
1.89T – 1.89T
+5.5% YoY
|
1.98T
1.94T – 2.03T
+4.6% YoY
|
| EBITDA |
126.77B
est: 160.47B (-21.0%)
|
155.82B
est: 194.41B (-19.8%)
|
137.17B
est: 175.29B (-21.7%)
|
140.07B
est: 182.86B (-23.4%)
|
114.24B
est: 180.53B (-36.7%)
|
118.79B
est: 176.64B (-32.8%)
|
168.07B
est: 170.77B (-1.6%)
|
197.67B
est: 182.27B (+8.4%)
|
226.85B
est: 217.63B (+4.2%)
|
232.76B
est: 235.23B (-1.1%)
|
209.22B
est: 247.70B (-15.5%)
|
254.28B
249.46B – 259.76B
+2.7% YoY
|
271.65B
269.30B – 277.47B
+6.8% YoY
|
287.63B
280.73B – 295.59B
+5.9% YoY
|
303.43B
303.30B – 303.56B
+5.5% YoY
|
317.40B
312.16B – 325.21B
+4.6% YoY
|
| EBIT |
81.19B
est: 103.85B (-21.8%)
|
104.97B
est: 125.82B (-16.6%)
|
90.90B
est: 113.44B (-19.9%)
|
88.28B
est: 118.34B (-25.4%)
|
61.76B
est: 116.83B (-47.1%)
|
56.80B
est: 114.32B (-50.3%)
|
105.02B
est: 110.52B (-5.0%)
|
131.44B
est: 117.96B (+11.4%)
|
155.03B
est: 140.85B (+10.1%)
|
154.46B
est: 153.91B (+0.4%)
|
122.76B
est: 162.07B (-24.3%)
|
166.38B
163.22B – 169.96B
+2.7% YoY
|
177.74B
176.20B – 181.55B
+6.8% YoY
|
188.20B
183.68B – 193.40B
+5.9% YoY
|
198.53B
198.44B – 198.62B
+5.5% YoY
|
207.67B
204.25B – 212.78B
+4.6% YoY
|
| Net Income |
46.50B
est: 77.97B (-40.4%)
|
71.29B
est: 59.09B (+20.6%)
|
53.07B
est: 42.90B (+23.7%)
|
60.12B
est: 51.16B (+17.5%)
|
29.70B
est: 18.42B (+61.2%)
|
18.84B
est: 23.65B (-20.3%)
|
59.42B
est: 44.68B (+33.0%)
|
75.73B
est: 65.79B (+15.1%)
|
94.07B
est: 83.33B (+12.9%)
|
87.12B
est: 158.92B (-45.2%)
|
70.27B
est: 94.81B (-25.9%)
|
134.68B
118.36B – 137.82B
+42.0% YoY
|
136.89B
125.04B – 155.09B
+1.6% YoY
|
158.85B
149.41B – 197.13B
+16.0% YoY
|
185.62B
178.71B – 231.04B
+16.9% YoY
|
234.49B
229.46B – 242.00B
+26.3% YoY
|
| SGA |
—
est: 242.79B (-100.0%)
|
268.72B
est: 294.15B (-8.6%)
|
265.57B
est: 265.21B (+0.1%)
|
275.13B
est: 276.67B (-0.6%)
|
273.43B
est: 273.14B (+0.1%)
|
274.60B
est: 267.26B (+2.7%)
|
268.50B
est: 258.38B (+3.9%)
|
281.12B
est: 275.78B (+1.9%)
|
313.51B
est: 329.28B (-4.8%)
|
339.73B
est: 351.21B (-3.3%)
|
366.85B
est: 369.82B (-0.8%)
|
379.66B
372.46B – 387.83B
+2.7% YoY
|
405.58B
402.08B – 414.27B
+6.8% YoY
|
429.45B
419.14B – 441.33B
+5.9% YoY
|
453.03B
452.84B – 453.23B
+5.5% YoY
|
473.89B
466.07B – 485.56B
+4.6% YoY
|
| EPS |
78.54
est: 77.41 (+1.5%)
|
121.23
est: 58.67 (+106.6%)
|
92.81
est: 42.60 (+117.9%)
|
106.84
est: 50.79 (+110.4%)
|
53.62
est: 18.29 (+193.2%)
|
34.37
est: 23.48 (+46.4%)
|
108.36
est: 44.36 (+144.3%)
|
139.42
est: 65.32 (+113.5%)
|
175.97
est: 82.29 (+113.8%)
|
167.44
est: 162.40 (+3.1%)
|
69.77
est: 96.89 (-28.0%)
|
133.42
121.59 – 141.58
+37.7% YoY
|
147.29
128.46 – 159.33
+10.4% YoY
|
173.99
153.49 – 202.52
+18.1% YoY
|
205.57
183.59 – 237.35
+18.2% YoY
|
240.90
235.73 – 248.61
+17.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-07 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-14 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-13 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-10 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael Lish | Executive Officer & Deputy GM of Bio & Fine Chemicals Division | 170M | — |
| Taro Fujie | Executive Chairman | 100M | male |
| Ikuo Kira | Executive MD & Managing Executive Officer | 97M | male |
| Shigeo Nakamura | President, Chief Executive Officer, Representative Executive Officer & Director | 83M | male |
| Hiroshi Shiragami | EVP, Representative Executive Officer, Chief Innovation Officer, R&D Head and Director | 69M | — |
| Naralice Fuzinelli | Global Technology Manager | — | female |
| Saburosuke Suzuki | Founder | — | male |
| Shino Kayahara | Executive Officer and In charge of Diversity & HR | — | — |
| Takayuki Koda | Executive Officer, Senior Vice President & Chief Digital Officer | — | male |
| Takayuki Tahara | Executive Officer, VP & Deputy GM of Food Products Div, Supervision of Food Products Sales | — | male |
| Ayumu Kamiya | Executive Officer & Deputy GM of Food Products Division | — | — |
| Yosuke Kakihara | Executive Officer of Legal & Compliance | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2802.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
